MedTrace Logo

The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom

NCT01270048 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2011-01-05

No results posted yet for this study

Summary

The purpose of this research is to examine the effect of Bunsimgi-eum on the chest discomfort of Hwa-byung's major symptom and develope and establish pattern identification system in Hwa-byung.

Conditions

  • Hwa-byung (Disorder)

Interventions

DRUG

mild-ex-gwarip

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

OTHER

Placebo

three times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • In-Chul Jung, Ph.D · Oriental Hospital of Daejon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-03-31
Completion
2009-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270048 on ClinicalTrials.gov